• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP
  • LOG IN

Rivus posts a win for its ex­per­i­men­tal obe­si­ty drug in heart fail­ure pa­tients

9 months ago
R&D

Fed­er­al judge rules against No­var­tis in En­tresto gener­ic law­suit

9 months ago
Pharma
FDA+

IRA price ne­go­ti­a­tion re­sults to be re­leased Thurs­day — re­port

9 months ago
Pharma
Law

Kyver­na shares safe­ty da­ta for CAR-T; Evotec gets $75M mile­stone

9 months ago
News Briefing

CSL Behring says up­take of he­mo­phil­ia B gene ther­a­py slow­er than ex­pect­ed

9 months ago
Pharma
Cell/Gene Tx

Gal­der­ma wins FDA ap­proval for IL-31 drug in chron­ic skin dis­ease

9 months ago
Pharma
FDA+

Ex­clu­sive: Gates Foun­da­tion backs start­up us­ing op­to­ge­net­ics to man­u­fac­ture bi­o­log­ics

9 months ago
Financing
R&D

Why a new health tech ven­ture firm is in­vest­ing on­ly in founders with a health­care back­ground

9 months ago
Financing
Health Tech

Law­mak­ers re­new calls for gov­ern­ment to fi­nal­ize march-in guid­ance

9 months ago
Pharma
FDA+

J&J re­ceives sup­port for $6.5B talc set­tle­ment — re­port

9 months ago
Pharma
Law

Pres­sure from an­ti-Chi­na leg­is­la­tion be­gins to rip­ple through bio­phar­ma

9 months ago
China
Pharma

Leg­end con­tin­ues Carvyk­ti fac­to­ry builds to ce­ment CAR-T ter­ri­to­ry with J&J

9 months ago
Pharma
Cell/Gene Tx

Re­vance to be ac­quired for $900M+ as Botox trade se­crets law­suit con­tin­ues

9 months ago
Deals

Cor­rect­ed: No­vo Nordisk to file in EU and Chi­na with late-phase in­sulin plus semaglu­tide da­ta – but not yet in the ...

9 months ago
R&D
FDA+

Three pa­pers on MD­MA are re­tract­ed by med­ical jour­nal, just a day af­ter Lykos' FDA re­jec­tion

9 months ago
R&D
Pharma

Tenax rais­es $100M; Sanofi buys in­to MeiraGTx

9 months ago
News Briefing

As­cendis scores FDA ap­proval for hy­poparathy­roidism can­di­date to re­place Takeda's pulled drug

9 months ago
Pharma
FDA+

Pfiz­er touts strength of RSV vac­cine in sub­group of younger im­muno­com­pro­mised pa­tients

9 months ago
R&D
Pharma

Hal­da adds $126M to test oral drugs for prostate, breast can­cer

9 months ago
Financing
Startups

FDA de­lays ap­proval de­ci­sion on Hu­ma­cyte’s lab-grown blood ves­sels

9 months ago
FDA+

Lat­est on MD­MA re­jec­tion; No­vo vs. Lil­ly earn­ings; Re­cur­sion, Ex­sci­en­tia to merge; Q&A with Genen­tech CEO; and more

9 months ago
Weekly

Lykos’ MD­MA-as­sist­ed PTSD treat­ment re­ject­ed by FDA af­ter trou­bled tri­al and push­back from ex­perts

9 months ago
Pharma
FDA+

Ohio fed­er­al judge dis­miss­es IRA suit brought by US Cham­ber of Com­merce

9 months ago
Pharma
Law

Am­gen an­nounces plans for new site in In­dia to strength­en AI, da­ta and life sci­ences

9 months ago
R&D
Pharma
First page Previous page 109110111112113114115 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times